Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement.
PMID:
Risk factors for osteonecrosis in patients with type 1 Gaucher's disease.
PMID:
Gaucher Disease in Bone: From Pathophysiology to Practice.
Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, Kindmark A, Mistry P, Poll L, Weinreb N, Deegan P.
J Bone Miner Res. 2019 Jun;34(6):996-1013. doi: 10.1002/jbmr.3734. Epub 2019 Jun 24.
PMID:31233632
Gaucher Disease.
Hughes DA, Pastores GM.
2000 Jul 27 [updated 2023 Dec 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301446
Gaucher disease.
Guggenbuhl P, Grosbois B, Chalès G.
Joint Bone Spine. 2008 Mar;75(2):116-24. doi: 10.1016/j.jbspin.2007.06.006. Epub 2007 Aug 31.
PMID:17996473
[Gaucher disease].
Nguyen Y, Stirnemann J, Belmatoug N.
Rev Prat. 2020 Apr;70(4):416-420.
PMID:32877100
Cytokines in Gaucher's disease.
Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S.
Eur Cytokine Netw. 1999 Jun;10(2):205-10.
PMID:10400826
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.
Basiri M, Ghaffari ME, Ruan J, Murugesan V, Kleytman N, Belinsky G, Akhavan A, Lischuk A, Guo L, Klinger K, Mistry PK.
Elife. 2023 May 30;12:e87537. doi: 10.7554/eLife.87537.
PMID:37249220
Deep learning-based quantification of osteonecrosis using magnetic resonance images in Gaucher disease.